French-multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

Leukemia

Volumn 11, Issue 7, 1997, Pages 1095-1106

  Chevillard, S ^a,t   Vielh, Ph ^a   Validire, P ^a   Marie, J P ^b   Faussat, A M ^b   Barbu, V ^c   Bayle, C ^d   Benard J ^d   Bonnal, C ^e   Boutonnat, J ^f   Calvo, F ^e   Charrier, J ^g   Clary, A ^h   Colosetti, P ⁱ   Danel Moore, L ^j   Decremoux P ^a,e   Delvincourt, C ^k   Finat Duclos, F ^l   Genne, Ph ^m   Kataki, A ⁱ   Kouyoumdjian, J C ⁿ   Lacave, R ^o   Maugard, C ^g   Merlin, J L ⁱ   Mousseau, M ^g   Pinguet, F ^p   Quillien, V ^q   Raphael, M ^r   Richard, B ^s   Verrelle, P ^l   Robert, J ^h   more..

^a INSTITUT CURIE   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f CHU La Tronche and University   (France)

^g CENTRE RENÉ GAUDUCHEAU   (France)

^h UNIVERSITÉ DE BORDEAUX   (France)

ⁱ CENTRE ALEXIS VAUTRIN   (France)

^j Institute de Chimie de'Rennes   (France)

^k INSTITUT JEAN GODINOT   (France)

^l CENTRE JEAN PERRIN   (France)

^m UNIVERSITÉ DE BOURGOGNE   (France)

ⁿ HENRI MONDOR HOSPITAL   (France)

^o HÔPITAL TENON   (France)

^p CENTRE VAL D AURELLE   (France)

^q CENTRE EUGÈNE MARQUIS   (France)

^r AVICENNE HOSPITAL   (France)

^s Etablissement de Transfus Sanguine   (France)

^t DSV DRR LCE   (France)

more..

Author keywords

Immunohistochemistry; Leukemia; Multidrug resistance; P glycoprotein; RT PCR; Solid tumor

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN P; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LEUKEMIA; LEUKEMIA CELL LINE; MULTICENTER STUDY; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; STANDARDIZATION;

EID: 16944364666     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400657     Document Type: Article

References (25)

1. Kemnitz J, Freund M, Dominis M, Cohnert TR, Uysal A, Georgii A. Detection of cells with multidrug-resistant phenotype in myeloproliferative disorders before therapy. Hematol Pathol 1989; 3: 73-78.
2. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Grant C, Lieber M, Cossman J, Gottesman MM, Pastan I. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-124.
3. Merkel DE, Fuqua SA, Tandon AK, Hill SM, Buzdar AU, McGuire WL. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 1989; 7: 1129-1136.
4. Marie JP, Zittoun R, Sikic BI. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586-592.
5. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J. Clinical relevance of immunohisto-chemical detection of multidrug resistance P-glycoprotein in breast carcinoma (see comments). J Natl Cancer Inst 1991; 83: 111-116.
6. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis (see comments). Blood 1992; 79: 473-176.
7. Gasparini G, Bevilacqua P, Pozza F, Meli S, Weidner N. P-glycoprotein expression predicts response to chemotherapy in previously untreated advanced breast cancer. Breast 1993; 2: 27-32.
8. Zhou DC, Ramond S, Viguie F, Faussat AM, Zittoun R, Marie JP. Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines. Int J Cancer 1996; 65: 365-371.
9. Akiyama S, Fojo A, Hanover JA, Pastan I, Gottesman MM. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 1985; 11: 117-126.
10. Chevillard S, Pouillart P, Beldjord C, Asselain B, Beuzeboc P, Magdelenat H, Vielh P. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 1996; 77: 292-300.
11. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160-7164.
12. Zhou DC, Zittoun R, Marie JP. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia 1995; 9: 1661-1666.
13. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996; 56: 3010-3020.
14. 3H] daunorubicin and MDR reversing agents. Anticancer Drugs 1996 (in press).
15. Merlin JL, Guerci A, Marchal S, Missoum N, Ramacci C, Humbert JC, Tsuruo T, Guerci O. Comparative evaluation of S9788, verapamil and cyclosporin A in K562 human leukemia cell lines and in P-glycoprotein expressing samples from patients with hematological malignancies. Blood 1994; 84: 262-269.
16. Guerci A, Merlin JL, Missoum N, Fedmann L, Marchal S, Rose C, Witz F, Guerci O. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood 1995; 85: 2147-2153.
17. Merlin JL, Marchal S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells. Cytometry 1995; 20: 315-323.
18. Abderrabi M, Marchal S, Merlin JL. Comparative in vitro evaluation of dithiane analogues of tiapamil, Ro 11-2933, Ro 44-5911 and Ro 44-5912 as multidrug resistance modulators. Anticancer Drugs 1996; 7: 430-436.
19. Genne P, Dimanche-Boitrel MT, Mauvernay RY, Gutierrez G, Duchamp O, Petit JM, Martin F, Chauffert B. Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo. Cancer Res 1992; 52: 2797-2801.
20. Genne Ph, Duchamp O, Solary E, Pinard D, Belon JP, Dimanche-Boitrel MT, Chauffert B. Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM. Leukemia 1994; 8: 160.
21. Vergier B, Cany L, Bonnet F, Robert J, de Mascarel A, Coindre JM. Expression of MDR1/P glycoprotein in human sarcomas. Br J Cancer 1993; 68: 1221-1226.
22. Chevillard S, Vielh P, Bastian G, Coppey J. A single 24 h contact time with adriamycin provokes the emergence of resistant cells expressing the Gp 170 protein. Anticancer Res 1992; 12: 495-500.
23. Bourhis J, Bénard J, Hartmann O, Boccon-Gibod L, Lemerle J, Riou G. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 1989; 82: 1493-1496.
24. Benard J, Bourhis J, de Vathaire J, Ferrandis E, Terrier-Lacombe MJ, Lemerle J, Riou G, Hartmann O. Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis. Adv Neuroblastoma Res 1994; 4: 111-116.
25. Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Mol Pharmacol 1995; 47: 51-56.